Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Use and abuse of flunitrazepam

M M Simmons1, M J Cupp

  • 1School of Pharmacy, West Virginia University, Morgantown 26506, USA.

The Annals of Pharmacotherapy
|February 26, 1998
PubMed
Summary

Flunitrazepam is unavailable in the US and offers no therapeutic benefit over existing benzodiazepines. Its illicit use as a "party drug" raises public health concerns, though its risk compared to other benzodiazepines remains unclear.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Goats with aspartic acid or serine at codon 146 of the PRNP gene remain scrapie-negative after lifetime exposure in affected herds in Cyprus.

Epidemiology and infection·2016
Same author

Altered trafficking of abnormal prion protein in atypical scrapie: prion protein accumulation in oligodendroglial inner mesaxons.

Neuropathology and applied neurobiology·2016
Same author

Does the Presence of Scrapie Affect the Ability of Current Statutory Discriminatory Tests To Detect the Presence of Bovine Spongiform Encephalopathy?

Journal of clinical microbiology·2015
Same author

Allelic variants at codon 146 in the PRNP gene show significant differences in the risk for natural scrapie in Cypriot goats.

Epidemiology and infection·2014
Same author

Four BSE cases with an L-BSE molecular profile in cattle from Great Britain.

The Veterinary record·2012
Same author

Minimal involvement of the circumventricular organs in the pathogenesis of spontaneously arising and experimentally induced classical bovine spongiform encephalopathy.

Journal of comparative pathology·2012

Area of Science:

  • Pharmacology
  • Public Health
  • Drug Policy

Background:

  • Flunitrazepam is a potent benzodiazepine not approved for medical use in the United States.
  • Its importation and possession are illegal within the US.
  • Existing benzodiazepines offer comparable therapeutic benefits without the associated illicit use profile.

Purpose of the Study:

  • To evaluate the therapeutic advantages of Flunitrazepam compared to currently marketed benzodiazepines in the US.
  • To assess the public health risks associated with Flunitrazepam's illicit use.
  • To review measures implemented to control its abuse.

Main Methods:

  • Literature review of pharmacological properties and clinical uses of Flunitrazepam.
  • Analysis of drug enforcement and public health data related to Flunitrazepam.
  • Comparative assessment of Flunitrazepam's risk profile against other benzodiazepines.

Main Results:

  • Flunitrazepam demonstrates no clear therapeutic advantage over US-marketed benzodiazepines.
  • Its rapid sedation, amnesia-inducing effects, and potentiation with alcohol contribute to its misuse.
  • Reported illicit uses include "party drug," "club drug," and "date rape drug" scenarios.
  • Various control measures have been enacted to mitigate its illegal distribution and use.

Conclusions:

  • Flunitrazepam's lack of therapeutic benefit in the US, coupled with its high potential for abuse, supports its restricted status.
  • The drug's association with recreational and criminal activities necessitates ongoing monitoring and control strategies.
  • Further research is required to definitively ascertain if Flunitrazepam presents a greater public health risk than other benzodiazepines.

Related Experiment Videos